Better Experience, Better Evidence:
How Human-centered Design Changes Clinical Trials

By: Bruce Hellman, Chief Patient Officer & Co-Founder and Ben James, Chief Design Officer & Co-Founder

In clinical research, innovation is often associated with new therapies, advanced biomarkers, or decentralized models. Yet one of the most powerful drivers of better trials is something even more fundamental: design. At uMotif, we believe human-centered design is essential to increasing patient engagement and capturing higher-quality data, and our experience in the market validates this premise.

Too many trials, however, are still constructed only around protocol efficiency and regulatory compliance. While these are non-negotiable, they can unintentionally create participant burden. Lengthy questionnaires, rigid digital experiences, unclear instructions, and disconnected workflows can make participation feel like a tedious task to complete rather than a contribution to meaningful research.

From day one, we’ve been committed to the philosophy of human-centered design and spent time working with the world’s experts, IDEO, to ensure that we incorporated best practices into our design approach.  

Using human-centered design for clinical trials starts by reframing the mission. Instead of focusing only on how to make patients comply with a protocol, we ask “how can we make clinical trial participation fit naturally into people’s daily lives to help drive engagement and retention?

High-quality clinical trial design directly impacts data completeness. When patients understand why they are reporting certain outcomes, and when the process feels straightforward and respectful of their time, completion rates improve. Consistency in reporting reduces missing data and minimizes the need for costly follow-up queries. High-frequency, low-friction inputs also can provide richer longitudinal insights, revealing patterns that site visits alone might miss.

Seemingly small design decisions can make a significant difference. Clear visual layouts reduce cognitive load. Intuitive navigation increases completion rates. Flexible notification timing respects individual schedules. Accessibility features ensure inclusion across age groups and abilities. When patients feel that a platform fits naturally into their lives, engagement becomes habitual, and even rewarding, rather than burdensome.

Trust is another critical factor. Participants are more likely to remain engaged when they feel informed and valued. Clear communication about how their data contributes to research, transparent privacy safeguards, and responsive support all reinforce partnership. When patients perceive themselves as collaborators rather than subjects, motivation increases.

Human-centered design also supports diversity and inclusion. Simplified interfaces, mobile-first functionality, and remote participation options can lower barriers for individuals who may not live near trial sites or who face mobility challenges. Broader participation strengthens the generalizability of findings and advances equity in research.

Ultimately, engagement and data quality are intertwined. Better experiences lead to better participation; better participation leads to more robust evidence. As clinical trials continue to evolve, embedding human-centered principles into digital tools is not simply a usability improvement—it’s a strategic imperative.

By designing with patients, not just for them, we can build trials that are more resilient, more inclusive, and more reflective of real-world experience.